Use of Approved Anti-CD38 Antibody Drug Product in Combination with Pomalidomide and Dexamethasone to Treat Multiple Myeloma | Patent Publication Number 20230233676
US 20230233676 A1Publication DateJul 27, 2023
Original Assignee
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsMing Qi
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.